Return to homepagePandemic Pact

Design, validation, and development of novel peptidomimetic therapeutics targeting SARS-CoV-2 replication.

Grant number: IPA/2020/000285

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    SERB India

  • Principal Investigator

    Dr. Arockiasamy Arulandu

  • Research Location

    India

  • Lead Research Institution

    International Centre for Genetic Engineering and Biotechnology (ICGEB) New Delhi

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

New or repurposed antivirals against valid viral targets, viricidal coatings

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Modes of Binding of Small Molecules Dictate the Interruption of RBD-ACE2 Complex of SARS-CoV-2.

Zinc2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro.